2nd Quarter - Report

PFIZER INC. for PFIZER INC.

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
—
Expenses
$1,780,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
2nd Quarter - Report (this page) Jul 21, 2015 $1,780,000 Replaced
2nd Quarter - Amendment Jul 21, 2015 $1,750,000 Yes

What was lobbied

7 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Deferral Comprehensive Tax Reform Territorial Systems Tax Extenders Patent Innovation Box

Contacted: U.S. Trade Representative (USTR); State, Dept of (DOS); Natl Security Council (NSC); SENATE; Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); Executive Office of the President (EOP); Commerce, Dept of (DOC); Patent & Trademark Office (PTO); Natl Economic Council (NEC); Treasury, Dept of; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Copyright/Patent/Trademark CPT

Patent Troll Legislation

LobbyistCovered position, as disclosed
PAULA BURG —
KEN W COLE —
JOHN PAUL HALLIWELL —
ANGELA WALKER RIEMER —
MARY BRIDGET WALSH —
JENNIFER SWENSON WALTON —

Contacted: Treasury, Dept of; U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); State, Dept of (DOS); Executive Office of the President (EOP); Health & Human Services, Dept of (HHS); Commerce, Dept of (DOC); Food & Drug Administration (FDA); Natl Security Council (NSC); Natl Economic Council (NEC); SENATE; Patent & Trademark Office (PTO)

Health Issues HCR

FDA Funding HHS Appropriations 340B Antibiotics Dormant Therapies FDA Breakthrough Therapies 21st Century Cures Initiative Senate Innovation Project

LobbyistCovered position, as disclosed
PAULA BURG —
KEN W COLE —
JOHN PAUL HALLIWELL —
ANGELA WALKER RIEMER —
MARY BRIDGET WALSH —
JENNIFER SWENSON WALTON —

Contacted: Centers For Medicare and Medicaid Services (CMS); Patent & Trademark Office (PTO); U.S. Trade Representative (USTR); Executive Office of the President (EOP); Treasury, Dept of; HOUSE OF REPRESENTATIVES; Natl Economic Council (NEC); Health & Human Services, Dept of (HHS); SENATE; Food & Drug Administration (FDA); Natl Security Council (NSC); Commerce, Dept of (DOC); State, Dept of (DOS)

Medicare/Medicaid MMM

Medicare Rebates/Medicare Part D Non-Interference SGR "Fix" Negotiations IPAB

LobbyistCovered position, as disclosed
PAULA BURG —
JOHN PAUL HALLIWELL —
ANGELA WALKER RIEMER —

Contacted: Centers For Medicare and Medicaid Services (CMS); U.S. Trade Representative (USTR); Patent & Trademark Office (PTO); HOUSE OF REPRESENTATIVES; Commerce, Dept of (DOC); Health & Human Services, Dept of (HHS); State, Dept of (DOS); Natl Economic Council (NEC); Executive Office of the President (EOP); Food & Drug Administration (FDA); SENATE; Natl Security Council (NSC); Treasury, Dept of

Alcohol and Drug Abuse ALC

STOPPAct (Stop the Tampering of Prescription Pills)

LobbyistCovered position, as disclosed
ANGELA WALKER RIEMER —

Contacted: Patent & Trademark Office (PTO); Treasury, Dept of; Centers For Medicare and Medicaid Services (CMS); Natl Security Council (NSC); State, Dept of (DOS); SENATE; Natl Economic Council (NEC); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); Food & Drug Administration (FDA); Executive Office of the President (EOP); Commerce, Dept of (DOC)

Consumer Issues/Safety/Products CSP

Preventing Abuse of Cough Treatment Act

LobbyistCovered position, as disclosed
ANGELA WALKER RIEMER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Natl Security Council (NSC); Health & Human Services, Dept of (HHS); Patent & Trademark Office (PTO); Centers For Medicare and Medicaid Services (CMS); Executive Office of the President (EOP); Commerce, Dept of (DOC); Treasury, Dept of; State, Dept of (DOS); Natl Economic Council (NEC); Food & Drug Administration (FDA); U.S. Trade Representative (USTR)

Trade (domestic/foreign) TRD

Trans Pacific Partnership Negotiations Miscellaneous Tariff Bill (MTB) Trans-Atlantic Trade & Investment Partnership (TTIP) Trade Promotion Authority/Fast-Track (TPA) Canada IP/Trade Issues South Africa IP Issues China IP Algeria Pricing Issues Saudia Arabia Pricing Issues WTO Trade Facilitation Agreement (TFA) Vietnam Distribution Trade Adjustment Assistance

Contacted: Natl Security Council (NSC); State, Dept of (DOS); Natl Economic Council (NEC); Executive Office of the President (EOP); U.S. Trade Representative (USTR); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Commerce, Dept of (DOC); SENATE; Food & Drug Administration (FDA); Treasury, Dept of; Patent & Trademark Office (PTO)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.